INTRODUCTION
Analgesics are one of the commonest group of drugs prescribed by a physician for pain. One of the greatest services doctors can do to their patients is to acquire knowledge and skills in the management of pain. 2 Pain can occur without tissue injury or evident disease and can persist after injury has healed. Under normal conditions, pain is associated with impulse activity in small-diameter (C and Aδ) primary afferent fibres of peripheral nerves. 1 These nerves have sensory endings in peripheral tissues and are activated by stimuli like mechanical, thermal and chemical. 18 The majorities of umyelinated (C) fibres is associated with polymodal nociceptive endings and convey a dull, diffuse, burning pain, whereas myelinated (Aδ) fibres convey a sensation of sharp, well-localized pain. C and Aδ fibres convey nociceptive information from muscle and viscera as well as from the skin. 2 Nociception is a consequence of tissue injury (trauma, inflammation) causing the release of chemical mediators which activate nociceptors, defined as receptors that are capable of distinguishing between noxious and innocuous stimuli in the tissue. 15 Studies indicate that it is also possible to increase sensitivity to noxious stimuli by activating histamine H receptors; mainly H 1 receptor. 6 It thus seems likely that the histaminergic system, like many other neuronal systems, plays an important role in the modulation of central perception of nociceptive stimuli.
(which act peripherally). The therapeutic efficacy of analgesics varies widely between individuals. They have a narrow therapeutic window and drug dosages may be limited to the onset of adverse reaction. 2 Existing analgesics are prone to cause serious side effects like GI bleeding, ulceration & renal toxicity. 21 So a search of drug for analgesia with good therapeutic effect and fewer side effects will be a boon for the patients.
Cetirizine is a second generation antihistaminic drug, popularly used for rhinitis, urticaria and conjunctivitis. It has got selective H1 antihistaminic activity. It has desirable pharmacokinetic properties with high safety profile.
14 In this study an attempt has been made to find whether Cetirizine, a second generation antihistaminic drug, has got any analgesic activity in mice.
METHODS

Materials:
Cetirizine10 mg oral tablet were obtained from GlaxoSmithKline.
The Institutional Animal Ethical committee permitted the study.
Animals: Swiss albino mice (20-25 g) of either sex obtained from King Institute Chennai were used for the experiments. The animals were maintained in standard environmental conditions and housed in a light-controlled room at a temperature of 24°C and a humidity of 60 ± 10% fed on a standard diet with water ad libitum.
Experimental protocol: The mice were randomly divided into 2 groups (n=5) as follows: The Analgesic effects were examined through tail flick, tail clip and tail immersion tests. 4, 5 Drugs were given once daily orally for 10 days to observe for chronic effect. Distilled water was used as a solvent for cetirizine. Reaction time of animals before and after drug will be noted at an interval of 0,15,30,60 and 90 minutes on day 1,3,5,7 and 10 for both acute and chronic effect.
Tail flick response:
This method is used to induce thermal pain stimuli. The tail of each mouse was placed on the nichrome wire of an analgesiometer, which was fixed at 5.5±0.5 amp. The time taken by the animal to withdraw (flick) its tail from the hot wire was taken as the reaction time. Cut off time is kept as 12 seconds. 5 Reaction time of animals before and after drug will be noted at an interval of 0,15,30,60 and 90 minutes.
Tail clip method:
All the mice were screened by applying a metal artery clip to the base of the tail with its jaw sheathed with thin rubber tubing. The pressure exerted by the clip was so adjusted that it was just sufficient to make all control mice respond.
This method was used to induce mechanical pain stimuli. A tail clip was applied and a positive analgesic response was indicated if there was no attempt to dislodge the clip within10 sec. Cut off time is kept as 10 seconds. Reaction time of animals before and after drug will be noted at an interval of 0,15,30,60 and 90 minutes.
Tail immersion method:
The tail (up to 5 cm) was then dipped in a beaker of water maintained at 55±0.5°C. The time in seconds to withdraw the tail clearly out of the water was taken as the reaction time. Cut off time is kept as 15 seconds. Reaction time of animals before and after drug will be noted at an interval of 0,15,30,60 and 90 minutes.
Statistical analysis:
Reaction times subjected to analysis using Microsoft excel software: mean±s.e.m. Significance given by p value <0.05. Multiple comparison was performed using one way ANOVA test followed by Tukey's multiple comparison tests was applied for the statistical analysis of the data in order to facilitate the comparisons of within group as well as inter-group differences.
RESULTS
Cetirizine administered at a dose of 1 mg/kg showed statistically significant analgesic activity in mice in all three tests used. Maximum possible analgesia was observed at 60 minutes after drug administration in all three tests.
Analgesic activity of cetirizine by tail-flick method
The mean reaction time of the cetirizine treated group after 15 and 30 minutes of drug administration was 5.6±0.57 and 8.4±0.59 seconds respectively (Table 1) It had statistically significant analgesic activity (p<0.001) in comparison with control group. The maximum possible analgesia was observed at 60 minutes after drug administration 10.4±0.57 sec (Figure 1 ) which is highly significant (p<0.001).
Analgesic activity of cetirizine by tail clip method
The mean reaction time of the cetirizine treated group after 15 and 30 minutes of drug administration was 3.04±0.32 and 7.88±0.91 seconds respectively (Table 2) . It had statistically significant analgesic activity (p<0.001) in comparison with control group. Here also the maximum possible analgesia was observed at 60 minutes after drug administration 10 seconds which is highly significant (p<0.001) in comparison with the control (Figure 2 ).
Analgesic activity of cetirizine by tail immersion method
The mean reaction time of the cetirizine treated group after 15 and 30 minutes of drug administration was 2.92±0.27 and 7.76 ±0.55 seconds respectively (Table 3) . This also showed statistically significant analgesic activity (p<0.001) in comparison with control group. Here also the maximum possible analgesia was observed at 60 minutes (11.7±0.48 seconds) after drug administration which is highly significant (p<0.001) in comparison with the control (Figure 3 ). 
In vivo antinociceptive activity in mice:
Cetirizine given by oral route in mice showed a significant and timedependent increase in analgesic activity in all the three tests used (Table 1, Table 2 and Table 3 ).
From these results it is clear that Cetirizine possesses central analgesic activity and chronic study (Figure 4) showed statistically significant increase in analgesic activity on day 10 when compared with day 1 at 15,30,60 and 90 minutes after drug administration (p<0.001). 
Day
DISCUSSION
In the present study, cetirizine was investigated for analgesic activity in mice. Cetirizine administered at a dose of 1 mg/kg showed statistically significant analgesic activity in mice and maximum possible analgesia was observed at one hour after drug administration.
Histamine is also released from local cells and directly excites nociceptors. 3 Several studies have demonstrated that histamine H 1 receptors play some role in physiological and pathological pain perception. The histaminergic neuron system arises from the tuberomammillary nucleus of the posterior hypothalamus receiving input mainly from the limbic system and projects efferent nerve fibers to almost all parts of the brain. 8 Studies suggests that histamine could modulate nociception at the cutaneous tissue level, the dorsal horn in the spinal cord and supraspinal including dorsal raphe nucleus in the medulla and periaqueductal gray in the midbrain through Histamine H 1 receptors. 6, 8 Central facilitation is an important component of pathological hyperalgesia (e.g. that associated with inflammatory responses). The mediators responsible for central facilitation include substance P, CGRP, nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF) and NO as well as many others. 15, 20 Histamine enhances nerve growth factor secretion in pain and inflammation. 10, 11, 13 Nerve growth factor (NGF) is a member of family of peptides known as neurotrophins. Recently, studies have shown that nerve growth factor (NGF) is a major mediator of inflammatory and neuropathic pain, providing a new therapeutic target. 9 Although originally discovered as a tropic factor for sympathetic and sensory neurons during development, it now appears that in adults, levels of NGF are elevated in many acute and chronic pain conditions. 19 Furthermore, preclinical animal models of inflammatory and neuropathic pain also show increased NGF levels 12 , while the sequestration of NGF alleviates the associated hyperalgesia. The molecular mechanisms involved are being elucidated. 9 Involvement of NGF in hyperalgesia has also been shown in human studies carried out as part of the first phase of clinical trials to assess the safety of NGF. 17 The patients reported muscle ache in response to systemically administered NGF. Subcutaneous injections resulted in local tenderness to touch and heat. 16 In our study, in addition to acute analgesic effect, chronic effect of the drug was also observed, which provides a support for the use of cetirizine as an analgesic clinically for both acute and chronic pain.
CONCLUSION
Cetirizine, a selective H 1 antihistaminic drug is found to have significant analgesic activity in mice (1 mg/kg dose). This effect might be due to blockade of H 1 histaminergic receptor, which mediates pain directly or indirectly by decreasing Nerve Growth Factor peptide level, as histamine has an influence on the secretion of Nerve Growth Factor peptide, which is responsible for hyperalgesia. This effect has to be studied further elaborately. Comparison of Cetirizine's analgesic activity with the standard is in progress in our next study. Further research would be of interest to explain the exact mechanism of this analgesic effect.
